Restriction mediated quantitative polymerase chain reactions
AssigneeMultiplicom NV
InventorJurgen Del Favero
Life of this patent
Estimating the term…
Loading patent…
AssigneeMultiplicom NV
InventorJurgen Del Favero
Estimating the term…
The present invention relates to the technical field of nucleic acid amplification using a Polymerase Chain Reaction (PCR). Specifically, the present invention relates to Polymerase Chain Reaction (PCR) primers and Polymerase Chain Reaction (PCR) nucleic acid amplification mixture and the use thereof in (quantitative) Polymerase Chain Reactions (PCR). Specifically, the present invention relates to Polymerase Chain Reaction (PCR) primers suitable for use in Restriction Mediated quantitative PCR (RM-qPCR) nucleic acid amplification reactions comprising a 5′ Acceptor representing one member of a fluorescence resonance energy transfer (FRET) pair; A representing a nucleic acid sequence motif of 10 to 30 bp; 3-C representing a linker region comprised of at least three carbon atoms; B representing a double stranded restriction enzyme recognition site or a random nucleic acid sequence; A′ representing a nucleic acid sequence motif of 10 to 30 bp being complementary to the nucleic acid sequence motif of A; and R-prim representing a nucleic acid sequence complementary to a target sequence in a nucleic acid sequence to be amplified.
A Polymerase Chain Reaction (PCR) nucleic acid amplification mixture comprising:
A method of performing Polymerase Chain Reaction (PCR) comprising amplifying a template comprising a target sequence with a PCR nucleic acid amplification mixture comprising:
Dependencies are inferred from the claim text.